Nifty Pharma Gains 2.98% on Broad-Based Strength
MarketPulse Summary: Nifty Pharma rose 2.98% (767.15 points) to 26,541.35, with 86 of 130 stocks advancing versus 43 declining. Piramal Pharma led gainers, up 17.15%. Smaller stocks averaged 0.98% gains against 0.63% for the top 10 by market capitalization, indicating balanced participation.
📊 Key Numbers
📈 Sector Performance
| Metric | Value |
|---|---|
| Index Level | 26,541.35 |
| Previous Close | 25,774.20 |
| Change | +2.98% |
| Change Points | 767.15 |
🎯 What drove the move?
Market reports provided contextual factors around the sector move, but the available evidence does not establish a single confirmed catalyst.
📊 Market Breadth
Across the broader Pharma stock universe used in this analysis, 43 of 130 stocks declined, while 86 advanced and 1 remained unchanged. Decliners represented 33.08%, compared with 66.15% for advancers. The breadth score was 33.08, indicating positive internal conditions. This universe should not be treated as the official index constituent universe unless separately verified.
| Category | Stocks | Share |
|---|---|---|
| Advancing | 86 | 66.15% |
| Declining | 43 | 33.08% |
| Unchanged | 1 | — |
| Breadth Score | 33.08 | |
🏢 Large Caps vs Smaller Stocks
The top 10 companies by market capitalization averaged 0.63%, while smaller stocks averaged 0.98%. The market-cap-weighted change was 0.94%, compared with a median change of 0.82% and a simple average of 0.95%. The leadership condition was balanced. The divergence indicates that the magnitude of the sector move was concentrated in larger companies.
🚀 Top Gainers
| Stock | LTP | % |
|---|---|---|
|
PPLPHARMA
Piramal Pharma Limited
|
₹232.80 | +17.15% |
|
AARTIDRUGS
Aarti Drugs Limited
|
₹447.90 | +11.35% |
|
SUDEEPPHRM
Sudeep Pharma Limited
|
₹1,119.00 | +9.45% |
|
SMSPHARMA
SMS Pharmaceuticals Limited
|
₹475.45 | +7.37% |
|
FDC
FDC Limited
|
₹376.55 | +6.43% |
📉 Top Losers
| Stock | LTP | % |
|---|---|---|
|
CONCORDBIO
Concord Biotech Limited
|
₹1,268.50 | -7.77% |
|
MEDICO
Medico Remedies Limited
|
₹19.22 | -5.88% |
|
MOREPENLAB
Morepen Laboratories Limited
|
₹125.58 | -4.99% |
|
NATCAPSUQ
Natural Capsules Limited
|
₹136.44 | -4.97% |
|
VENUSREM
Venus Remedies Limited
|
₹1,330.20 | -4.22% |
🏦 Largest Companies
Among the top gainers, Piramal Pharma Limited gained 17.15% to 232.80, Aarti Drugs Limited gained 11.35% to 447.90, Sudeep Pharma Limited gained 9.45% to 1,119.00. On the losing side, Concord Biotech Limited fell 7.77% to 1,268.50, Medico Remedies Limited fell 5.88% to 19.22, Morepen Laboratories Limited fell 4.99% to 125.58. Among the largest companies, Sun Pharmaceutical Industries Limited gained 0.36%, Divi's Laboratories Limited gained 0.56%, Torrent Pharmaceuticals Limited declined 1.47%, Zydus Lifesciences Limited gained 0.22%, Cipla Limited gained 1.16%. The available research does not establish specific reasons for individual stock moves.
| Stock | Market Cap | LTP | % |
|---|---|---|---|
|
SUNPHARMA
Sun Pharmaceutical Industries Limited
|
4,60,672cr | ₹1,757.50 | +0.36% |
|
DIVISLAB
Divi's Laboratories Limited
|
2,45,266cr | ₹9,558.50 | +0.56% |
|
TORNTPHARM
Torrent Pharmaceuticals Limited
|
1,92,086cr | ₹4,557.00 | -1.47% |
|
ZYDUSLIFE
Zydus Lifesciences Limited
|
1,18,803cr | ₹1,175.50 | +0.22% |
|
CIPLA
Cipla Limited
|
1,14,999cr | ₹1,365.60 | +1.16% |
|
LAURUSLABS
Laurus Labs Limited
|
1,04,740cr | ₹2,181.90 | +1.86% |
|
LUPIN
Lupin Limited
|
99,295cr | ₹1,972.70 | +1.06% |
|
MANKIND
Mankind Pharma Limited
|
98,413cr | ₹2,490.00 | -0.50% |
|
DRREDDY
Dr. Reddy's Laboratories Limited
|
98,325cr | ₹1,335.40 | +1.94% |
|
AUROPHARMA
Aurobindo Pharma Limited
|
94,667cr | ₹1,644.80 | +1.06% |
📝 What the data suggests
Broad-based pharma sector rally
The data shows positive internal sector conditions. The relationship between breadth, large-cap performance and smaller-stock performance should be considered when interpreting the move.
👀 What to watch next
The divergence between large-cap and smaller stocks remains relevant to the sector's internal structure. The broad-based pharma sector rally remains the key data-supported theme.
📊 Track Live Markets
Real-time Nifty data, sector performance, market breadth, stock movers and AI-powered analysis.
Open Dashboard →Data generated at 28 Oct 2026. Not investment advice.